test_cases:
  # ========================================
  # TRIALS BY MOLECULE
  # ========================================
  - id: "imatinib_trials_001"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_molecule"
      molecule: "imatinib"
    expected_facts:
      required:
        - "Trials linked to imatinib are returned"
      optional:
        - "NCT IDs are included"
        - "CML or GIST trials included"
    source: "ClinicalTrials.gov"
    confidence: "high"

  - id: "pembrolizumab_trials_002"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_molecule"
      molecule: "pembrolizumab"
    expected_facts:
      required:
        - "Trials linked to pembrolizumab are returned"
      optional:
        - "KEYNOTE trials may be included"
        - "Cancer trials included"
    source: "ClinicalTrials.gov"
    confidence: "high"

  - id: "metformin_trials_003"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_molecule"
      molecule: "metformin"
    expected_facts:
      required:
        - "Trials linked to metformin are returned"
      optional:
        - "Diabetes trials included"
        - "Oncology repurposing trials may appear"
    source: "ClinicalTrials.gov"
    confidence: "high"

  - id: "trastuzumab_trials_bio_026"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_molecule"
      molecule: "trastuzumab"
      molecule_type: "biotherapeutic"
    expected_facts:
      required:
        - "Trials linked to trastuzumab are returned"
      optional:
        - "HER2 or ERBB2 trials included"
        - "Breast cancer trials included"
    source: "ClinicalTrials.gov"
    confidence: "high"

  # ========================================
  # MOLECULES BY CONDITION
  # ========================================
  - id: "breast_cancer_molecules_004"
    tool: "search_molecule_trials"
    input:
      mode: "molecules_by_condition"
      condition: "breast cancer"
    expected_facts:
      required:
        - "Molecules associated with breast cancer trials are returned"
      optional:
        - "trastuzumab is included"
        - "palbociclib is included"
        - "tamoxifen is included"
    source: "ClinicalTrials.gov"
    confidence: "high"

  - id: "diabetes_molecules_005"
    tool: "search_molecule_trials"
    input:
      mode: "molecules_by_condition"
      condition: "type 2 diabetes"
    expected_facts:
      required:
        - "Molecules associated with diabetes trials are returned"
      optional:
        - "metformin is included"
        - "insulin is included"
    source: "ClinicalTrials.gov"
    confidence: "high"

  - id: "melanoma_molecules_006"
    tool: "search_molecule_trials"
    input:
      mode: "molecules_by_condition"
      condition: "melanoma"
    expected_facts:
      required:
        - "Molecules associated with melanoma trials are returned"
      optional:
        - "pembrolizumab is included"
        - "nivolumab is included"
        - "vemurafenib is included"
    source: "ClinicalTrials.gov"
    confidence: "high"

  - id: "melanoma_biotherapeutics_028"
    tool: "search_molecule_trials"
    input:
      mode: "molecules_by_condition"
      condition: "melanoma"
      molecule_type: "biotherapeutic"
    expected_facts:
      required:
        - "Biotherapeutic molecules associated with melanoma trials are returned"
      optional:
        - "pembrolizumab is included"
        - "nivolumab is included"
    source: "ClinicalTrials.gov"
    confidence: "high"

  # ========================================
  # TRIALS BY TARGET
  # ========================================
  - id: "egfr_target_trials_007"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_target"
      target_gene: "EGFR"
    expected_facts:
      required:
        - "Trials linked to EGFR-targeting molecules are returned"
      optional:
        - "erlotinib trials included"
        - "gefitinib trials included"
        - "Lung cancer trials included"
    source: "ClinicalTrials.gov"
    confidence: "high"

  - id: "egfr_small_molecule_trials_029"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_target"
      target_gene: "EGFR"
      molecule_type: "small_molecule"
    expected_facts:
      required:
        - "Trials linked to EGFR-targeting molecules are returned"
      optional:
        - "erlotinib trials included"
        - "gefitinib trials included"
    source: "ClinicalTrials.gov"
    confidence: "high"

  - id: "pdcd1_biotherapeutic_trials_030"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_target"
      target_gene: "PDCD1"
      molecule_type: "biotherapeutic"
    expected_facts:
      required:
        - "Trials linked to PDCD1-targeting biotherapeutics are returned"
      optional:
        - "pembrolizumab trials included"
        - "nivolumab trials included"
    source: "ClinicalTrials.gov"
    confidence: "high"

  - id: "erbb2_biotherapeutic_trials_031"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_target"
      target_gene: "ERBB2"
      molecule_type: "biotherapeutic"
    expected_facts:
      required:
        - "Trials linked to ERBB2-targeting biotherapeutics are returned"
      optional:
        - "trastuzumab trials included"
    source: "ClinicalTrials.gov"
    confidence: "high"

  - id: "jak2_target_trials_008"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_target"
      target_gene: "JAK2"
    expected_facts:
      required:
        - "Trials linked to JAK2-targeting molecules are returned"
      optional:
        - "ruxolitinib trials included"
        - "Myelofibrosis or MPN trials included"
    source: "ClinicalTrials.gov"
    confidence: "high"

  # Additional Target â†’ Trial test cases (well-established targets)
  - id: "abl1_target_trials_011"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_target"
      target_gene: "ABL1"
    expected_facts:
      required:
        - "Trials linked to ABL1-targeting molecules are returned"
      optional:
        - "imatinib trials included"
        - "dasatinib trials included"
        - "CML or ALL trials included"
    source: "ClinicalTrials.gov"
    confidence: "high"

  - id: "braf_target_trials_012"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_target"
      target_gene: "BRAF"
    expected_facts:
      required:
        - "Trials linked to BRAF-targeting molecules are returned"
      optional:
        - "vemurafenib trials included"
        - "dabrafenib trials included"
        - "Melanoma trials included"
    source: "ClinicalTrials.gov"
    confidence: "high"

  - id: "alk_target_trials_013"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_target"
      target_gene: "ALK"
    expected_facts:
      required:
        - "Trials linked to ALK-targeting molecules are returned"
      optional:
        - "crizotinib trials included"
        - "alectinib trials included"
        - "Lung cancer or NSCLC trials included"
    source: "ClinicalTrials.gov"
    confidence: "high"

  - id: "cdk4_target_trials_014"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_target"
      target_gene: "CDK4"
    expected_facts:
      required:
        - "Trials linked to CDK4-targeting molecules are returned"
      optional:
        - "palbociclib trials included"
        - "ribociclib trials included"
        - "Breast cancer trials included"
    source: "ClinicalTrials.gov"
    confidence: "high"

  - id: "vegfr2_target_trials_015"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_target"
      target_gene: "KDR"
    expected_facts:
      required:
        - "Trials linked to KDR/VEGFR2-targeting molecules are returned"
      optional:
        - "sunitinib trials included"
        - "sorafenib trials included"
        - "Renal cell carcinoma trials included"
    source: "ClinicalTrials.gov"
    confidence: "high"

  - id: "mtor_target_trials_016"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_target"
      target_gene: "MTOR"
    expected_facts:
      required:
        - "Trials linked to MTOR-targeting molecules are returned"
      optional:
        - "everolimus trials included"
        - "temsirolimus trials included"
    source: "ClinicalTrials.gov"
    confidence: "high"

  - id: "met_target_trials_017"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_target"
      target_gene: "MET"
    expected_facts:
      required:
        - "Trials linked to MET-targeting molecules are returned"
      optional:
        - "capmatinib trials included"
        - "tepotinib trials included"
        - "NSCLC or hepatocellular carcinoma trials"
    source: "ClinicalTrials.gov"
    confidence: "high"

  # ========================================
  # TRIALS BY SEQUENCE
  # ========================================
  - id: "vh_motif_trials_032"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_sequence"
      sequence: "EVQLVESGG"
      molecule_type: "biotherapeutic"
    expected_facts:
      required:
        - "Trials linked to biotherapeutics with EVQLVESGG motif are returned"
      optional:
        - "Antibody trials included"
    source: "ClinicalTrials.gov + ChEMBL"
    confidence: "medium"

  - id: "vl_motif_trials_033"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_sequence"
      sequence: "DIQMTQ"
      molecule_type: "biotherapeutic"
    expected_facts:
      required:
        - "Trials linked to biotherapeutics with DIQMTQ motif are returned"
      optional:
        - "Antibody trials included"
    source: "ClinicalTrials.gov + ChEMBL"
    confidence: "medium"

  # ========================================
  # TRIALS BY STRUCTURE (Similarity Search)
  # ========================================
  - id: "imatinib_structure_trials_018"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_structure"
      smiles: "Cc1ccc(cc1Nc2nccc(n2)c3cccnc3)NC(=O)c4ccc(cc4)CN5CCN(CC5)C"
      similarity_threshold: 0.7
    expected_facts:
      required:
        - "Trials for imatinib or structurally similar molecules are returned"
      optional:
        - "imatinib trials included"
        - "Related kinase inhibitor trials may appear"
        - "CML or GIST trials included"
    source: "ClinicalTrials.gov + ChEMBL"
    confidence: "high"

  - id: "erlotinib_structure_trials_019"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_structure"
      smiles: "COCCOc1cc2c(cc1OCCOC)ncnc2Nc3cccc(c3)C#C"
      similarity_threshold: 0.7
    expected_facts:
      required:
        - "Trials for erlotinib or similar EGFR inhibitors are returned"
      optional:
        - "erlotinib trials included"
        - "NSCLC trials included"
    source: "ClinicalTrials.gov + ChEMBL"
    confidence: "high"

  - id: "aspirin_structure_trials_020"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_structure"
      smiles: "CC(=O)Oc1ccccc1C(=O)O"
      similarity_threshold: 0.6
    expected_facts:
      required:
        - "Trials for aspirin or similar salicylates are returned"
      optional:
        - "aspirin or acetylsalicylic acid trials included"
        - "Cardiovascular trials included"
    source: "ClinicalTrials.gov + ChEMBL"
    confidence: "high"

  - id: "sunitinib_structure_trials_021"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_structure"
      smiles: "CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc23)c1C"
      similarity_threshold: 0.7
    expected_facts:
      required:
        - "Trials for sunitinib or similar kinase inhibitors are returned"
      optional:
        - "sunitinib trials included"
        - "Renal cell carcinoma or GIST trials"
    source: "ClinicalTrials.gov + ChEMBL"
    confidence: "high"

  # ========================================
  # TRIALS BY SUBSTRUCTURE
  # ========================================
  - id: "quinazoline_substructure_trials_022"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_substructure"
      smiles: "c1ccc2ncnc(N)c2c1"
    expected_facts:
      required:
        - "Trials for molecules containing aminoquinazoline substructure are returned"
      optional:
        - "EGFR inhibitors may be included (gefitinib, erlotinib share this scaffold)"
        - "Lung cancer trials may appear"
    source: "ClinicalTrials.gov + ChEMBL"
    confidence: "medium"

  - id: "indole_substructure_trials_023"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_substructure"
      smiles: "c1ccc2[nH]ccc2c1"
    expected_facts:
      required:
        - "Trials for molecules containing indole substructure are returned"
      optional:
        - "Sunitinib or related indolinone compounds may appear"
    source: "ClinicalTrials.gov + ChEMBL"
    confidence: "medium"

  - id: "pyrimidine_substructure_trials_024"
    tool: "search_molecule_trials"
    input:
      mode: "trials_by_substructure"
      smiles: "c1ncncn1"
    expected_facts:
      required:
        - "Trials for molecules containing pyrimidine are returned"
      optional:
        - "Many kinase inhibitors contain pyrimidine"
        - "Imatinib-type compounds may appear"
    source: "ClinicalTrials.gov + ChEMBL"
    confidence: "medium"

  # ========================================
  # DRUG TRIALS (via pharmacology search)
  # ========================================
  - id: "imatinib_drug_trials_009"
    tool: "search_drug_trials"
    input:
      drug_name: "imatinib"
    expected_facts:
      required:
        - "Clinical trials for imatinib are returned"
      optional:
        - "NCT IDs are included"
        - "Trial phases shown"
        - "Trial status shown"
    source: "ClinicalTrials.gov"
    confidence: "high"

  - id: "trastuzumab_drug_trials_010"
    tool: "search_drug_trials"
    input:
      drug_name: "trastuzumab"
    expected_facts:
      required:
        - "Clinical trials for trastuzumab are returned"
      optional:
        - "Breast cancer trials included"
        - "HER2 mentioned"
    source: "ClinicalTrials.gov"
    confidence: "high"
